In terms of mechanisms, one study revealed that METTL3 can elevate the expression of MYC mRNA and protein levels by increasing the m6A level of the MYC transcript, which leads to carcinogenesis of prostate cancer [94]. Here, MYC is linked to prostate carcinoma.